Stock Trading Of NBIX

Owners: 134

Buying: 35 (26.11%)

No Change: 20 (14.92 %)

Selling: 75 (55.97 %)

Stock Trading Score: 2.55

Brand New: 15

Added More: 20

No Change: 20

Sold Some: 53

Sold All: 22

No Compare: 4

Name: Neurocrine Biosciences Inc

Last Trade: 2010-03-10

Country: United States

Industry: Therapeutics

Address: 12790 El Camino Real,San Diego, Ca 92130,,United States Phone: 858-617-7600 Fax: 858-617-7601 Website: HTTP://WWW.NEUROCRINE.COM
ISIN: US64125C1099
CUSIP: 64125C109

Therapeutics Industry Stocks Bought Therapeutics Industry Stocks Sold

NBIX Stock Trading

Show ALL transactions instead of just the most recent 10:
Use 'As-Of/On' instead of 'Filed' for dates: Begin date: End date:
A begin price of 1900-01-01 will use the date filed for begin price: Begin Price date: End Price date:
- report date span limited to 100 days, all dates in format of yyyy-mm-dd, all fields required!

Transactions: Currently showing holdings/transactions Filed between 2009-12-10 and 2010-03-10 and using base stock prices on Filing Date compared to stock prices on 2010-03-19

Show/Hide Columns Of Stock Trading Details

Filed As Of/On Form Name
Fundclass Shares Activity Shares Change
Shares Change Pct. Hypothetical Old Value Hypothetical New Value Hypothetical Value Change
Hypothetical Return Hypothetical Results Director Ten Pct

Other Officer Officer Title History

Stock Trading: Ten Trades Most Recently Reported

Filed	As-Of/On	Form	Fullname	Fund Class	Shares	Activity	Shares Change	Shares Pct. Change	Hypothetical Old Value	Hypothetical New Value	Hypothetical Value Chg.	Hypotheticals Return	Hypotheticals Results	History
2010-03-10	2009-12-31	N-CSR	Rydex Dynamic Funds - Dow 2x Strategy Master Fund	Specialty & Misc	782	New Holding	782	100 %	$1,861	$2,127	$266	14.28 %	$266	Stock Trading of Neurocrine Biosciences Inc By Rydex Dynamic Funds - Dow 2x Strategy Master Fund
2010-03-10	2009-12-31	N-CSR	Rydex Series Funds - Banking Fund	Financial Services	680	Sold Some	-171	-20.09 %	$1,618	$1,850	$231	14.28 %	$-58	Stock Trading of Neurocrine Biosciences Inc By Rydex Series Funds - Banking Fund
2010-03-10	2009-12-31	N-CSR	Rydex Variable Trust - Biotechnology Fund	Health/Biotech	407	Sold Some	-30	-6.86 %	$969	$1,107	$138	14.28 %	$-10	Stock Trading of Neurocrine Biosciences Inc By Rydex Variable Trust - Biotechnology Fund
2010-03-10	2009-12-31	N-CSR	Jnl Series Trust - Jnlmcm Small Cap Index Fund A	Small-Cap Core	19	No Compare			$45	$52	$6	14.28 %		Stock Trading of Neurocrine Biosciences Inc By Jnl Series Trust - Jnlmcm Small Cap Index Fund A
2010-03-09	2009-12-31	N-CSR	Westcore Trust - Westcore Micro-Cap Opportunity Fund	No Data	4,903	New Holding	4,903	100 %	$11,571	$13,336	$1,765	15.25 %	$1,765	Stock Trading of Neurocrine Biosciences Inc By Westcore Trust - Westcore Micro-Cap Opportunity Fund
2010-03-09	2009-12-31	N-CSR	Pacific Select Fund - Small-Cap Index Portfolio	No Data	20,588	Sold Some	-700	-3.28 %	$48,588	$55,999	$7,412	15.25 %	$-252	Stock Trading of Neurocrine Biosciences Inc By Pacific Select Fund - Small-Cap Index Portfolio
2010-03-09	2009-12-31	N-CSR	Pacific Select Fund - Pd Small-Cap Growth Index Portfolio	No Data	1,144	Added More	341	42.46 %	$2,700	$3,112	$412	15.25 %	$123	Stock Trading of Neurocrine Biosciences Inc By Pacific Select Fund - Pd Small-Cap Growth Index Portfolio
2010-03-05	2009-12-31	13F-HR/A	Royal Bank Of Canada	Institution	1,500	New Holding	1,500	100 %	$3,450	$4,080	$630	18.26 %	$630	Stock Trading of Neurocrine Biosciences Inc By Royal Bank Of Canada
2010-03-05	2009-12-31	N-CSR	Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio	Small-Cap Growth	29,300	No Change	0	0 %	$67,390	$79,696	$12,306	18.26 %	$0	Stock Trading of Neurocrine Biosciences Inc By Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio
2010-03-05	2009-12-31	N-CSR	Axa Premier Vip Trust - Axa Aggressive Allocation Portfolio	Specialty & Misc	3,100	No Compare			$7,130	$8,432	$1,302	18.26 %		Stock Trading of Neurocrine Biosciences Inc By Axa Premier Vip Trust - Axa Aggressive Allocation Portfolio

Returned 10 Records!

About Terms Contact FAQ Press Releases

Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss!
There has been no adjustmentsfor splits!

Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate!

Copyright © 2005 All rights reserved. Please see our Terms of Use.